Continuous Glucose Monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Samsung unveils plans for innovative non-invasive glucose monitoring technology, challenging health giants like Apple.

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...

Dexcom bet on the high financial ceiling that exists by integrating its glucose monitoring capabilities into the ring, ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM ... on the FDA’s website, but the wearable device has a similar indication to Stelo ...

Forget going to the doctor’s office; these companies are putting the power of tracking every aspect of your health into our ...

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors ... s claims for its wearable blood sugar ...